HOME >> MEDICINE >> NEWS
Researchers develop 'genetic blueprint' to predict response to esophageal cancer treatments

ANAHEIM - For the first time, researchers appear to be able to use a comprehensive panel of genetic variants to predict how a patient with esophageal cancer will respond to a spectrum of cancer treatments.

At the annual meeting of the American Association for Cancer Research (AACR), researchers from The University of Texas M. D. Anderson Cancer Center report that six different gene variants can predict an improved outcome in patients treated with two different chemotherapy drugs and/or with radiation therapy.

For example, the researchers say that a combination of several gene variants in patients treated with one type of chemotherapy (5-FU) more than doubled survival to 51 months, compared to 25 months in patients treated with the same drug who did not have these variants.

They say the findings represent a leap forward in the goal to provide tailored therapy to individual patients because it offers a genetic blueprint for gauging the potential effectiveness of all common esophageal cancer treatment, not just an analysis of how one or two "candidate" genes respond to a single treatment.

"Our data strongly suggest that combined pathway-based analysis may provide powerful clinical outcome predictors for esophageal cancer as well as for other cancers," says the study's lead author Xifeng Wu, M.D., Ph.D., a professor in the Department of Epidemiology.

"This points to a promising new direction for cancer pharmacogenetics," she says. "Our hope is to have a gene chip one day that can analyze a patient's genetic makeup and help physicians predict response to a wide variety of therapeutic drugs before treatment even begins."

Esophageal cancer is highly aggressive; approximately 14,520 new esophageal cancer cases and 13,570 associated deaths are expected in 2005, according to the American Cancer Society. Almost half of new cases are diagnosed at an advanced stage, when the five-year survival rate is just 14 percent. Surgery
'"/>

Contact: Nancy Jensen
nwjensen@mdanderson.org
713-792-0655
University of Texas M. D. Anderson Cancer Center
19-Apr-2005


Page: 1 2 3

Related medicine news :

1. Researchers suggest TB screening for all international adoptees
2. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
3. Researchers link metal ions to neurodegenerative disease
4. Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases
5. Researchers call for investigation into links between khat use and psychiatric disorders
6. Researchers use MRI to predict recovery after spinal cord injury
7. Researchers find deadly prescription drug effects 6 years before FDA
8. Researchers investigate impact of lifestyle on GI health
9. Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
10. Researchers discover how antibiotic inhibits bacterial growth
11. Researchers urge caution in using ESAs for cancer-related anemia

Post Your Comments:
(Date:5/30/2015)... Cyclist Barry Haarde will commence his ... 2015: Piles of Miles” near San Francisco, California ... and encourage individuals to support needy hemophilic children ... Life supports nearly 1,200 impoverished children and adults ... sponsorships, scholarships and micro-enterprise grants. Hemophilia is a ...
(Date:5/30/2015)... iconic American actor, and host of “In America” James ... Medical Malpractice. This segment of “In America” will cover ... field. , According to the Bureau of Justice Statistics, ... roughly only 20% of them made it to court, ... remaining 30% were tossed out. (Source: http://www.bjs.gov/index.cfm?ty=tp&tid=4511 ) ...
(Date:5/30/2015)... May 30, 2015 Venus Viva has ... scars, large pores, deep wrinkles, stretch marks, pigmentation irregularities, ... professional, such as Dr. F. Victor Rueckl of Lakes ... clinical trials in Las Vegas. This body image solution ... a system that delivers proven results through a skin ...
(Date:5/29/2015)... Based in St. Louis, Missouri La La ... for a couple of months now and are really helping ... reads “I’m not misbehaving, I have Autism, please be understanding” ... an autistic child in order to start a conversation and ... are they raising awareness through the autism awareness shirts which ...
(Date:5/29/2015)... Washington, PA (PRWEB) May 29, 2015 ... ” quiz-based learning in 14 medical specialties, now offers ... includes a wide spectrum of rheumatology disorders ranging from ... Alfred Saint Jacques, editorial director of MDLinx, and Caroline ... excited about the impact it will have on the ...
Breaking Medicine News(10 mins):Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2Health News:MDLinx Launches Smartest Rheumatologist 2
(Date:5/29/2015)... , May 29, 2015  Anpac Bio-Medical Science Co., ... Yu and the Anpac research team are introducing ... Science (NPLS) organizers published as, "game changing" and "breakthrough" ... Society of Clinical Oncology (ASCO) Annual Meeting in ... 2, 2015. An accomplished inventor with ...
(Date:5/29/2015)... , May 29, 2015  Fair Rate Funding, ... a state-court jury in Delaware ... inserts, designed to treat pelvic organ prolapse (POP) and ... and that company executives hid the design flaws from ... - http://photos.prnewswire.com/prnh/20150529/219354LOGO Transvaginal mesh, ...
(Date:5/29/2015)... Actinobac Biomed, NovoPedics, Inc. and MentiNova, Inc., ... Foundation Venture Capital Group (FVCG), have been selected to ... of the Start-Up Stadium and Company Presentation forums offered ... Golubieski . The annual convention, the largest ... in Philadelphia in June. ...
Breaking Medicine Technology:Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 2Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 3TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 2TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 3Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3
Cached News: